平缓新冠疫苗拒绝曲线——一项国际综述
Flattening the Curve of COVID-19 Vaccine Rejection-An International Overview.
作者信息
Feleszko Wojciech, Lewulis Piotr, Czarnecki Adam, Waszkiewicz Paweł
机构信息
Department of Pediatric Pulmonology and Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.
Department of Criminalistics, University of Warsaw, 00-927 Warsaw, Poland.
出版信息
Vaccines (Basel). 2021 Jan 13;9(1):44. doi: 10.3390/vaccines9010044.
BACKGROUND
If globally implemented, a safe coronavirus disease 2019 (COVID-19) vaccination program will have broad clinical and socioeconomic benefits. However, individuals who anticipate that the coronavirus vaccine will bring life back to normality may be disappointed, due to the emerging antivaccination attitude within the general population.
METHODS
We surveyed a sample of adult Polish citizens ( = 1066), and compared it with the data on international COVID-19 vaccine reluctance.
RESULTS
In 20 national surveys, the vaccine averseness for the anticipated COVID-19 vaccine varied from meager (2-6% China) to very high (43%, Czech Republic, and 44%, Turkey) and in most countries was much higher than regular vaccination reluctance, which varies between 3% (Egypt) and 55% (Russia).
CONCLUSIONS
These results suggest that a 67% herd immunity may be possible only if mandatory preventive vaccination programs start early and are combined with coordinated education efforts supported by legislative power and social campaigns.
背景
如果在全球范围内实施，一项安全的2019冠状病毒病（COVID-19）疫苗接种计划将带来广泛的临床和社会经济效益。然而，由于普通人群中出现的反疫苗态度，那些期望冠状病毒疫苗能让生活恢复正常的人可能会感到失望。
方法
我们对波兰成年公民样本（n = 1066）进行了调查，并将其与国际上关于COVID-19疫苗犹豫的数据进行了比较。
结果
在20项全国性调查中，对预期的COVID-19疫苗的厌恶程度从很低（中国为2%-6%）到非常高（捷克共和国为43%，土耳其为44%）不等，而且在大多数国家，这种厌恶程度远高于常规疫苗接种犹豫，常规疫苗接种犹豫在3%（埃及）至55%（俄罗斯）之间。
结论
这些结果表明，只有早期启动强制性预防接种计划，并结合立法权力和社会运动支持的协调教育努力，才有可能实现67%的群体免疫。
Zotero 插件